Exact Mass: 508.2144

Exact Mass Matches: 508.2144

Found 175 metabolites which its exact mass value is equals to given mass value 508.2144, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

6-O-Oleuropeoylsucrose

[(2R,3S,4S,5R,6R)-6-{[(2S,3S,4S,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 4-(2-hydroxypropan-2-yl)cyclohex-1-ene-1-carboxylic acid

C22H36O13 (508.2156)

6-O-Oleuropeoylsucrose is a constituent of the root bark of the olive (Olea europaea). Constituent of the root bark of the olive (Olea europaea)

Tert-butyl N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-propan-2-yloxyamino]-1-phenylbutan-2-yl]carbamate

N-(3-{[(tert-butoxy)(hydroxy)methylidene]amino}-2-hydroxy-4-phenylbutyl)-4-methoxy-N-(propan-2-yloxy)benzene-1-sulphonamide

C25H36N2O7S (508.2243)

Belnacasan

1-(2-{[(4-amino-3-chlorophenyl)(hydroxy)methylidene]amino}-3,3-dimethylbutanoyl)-N-(2-ethoxy-5-oxooxolan-3-yl)pyrrolidine-2-carboximidate

C24H33ClN4O6 (508.2089)

Mortonin C

(5alpha,5abeta,6beta,9alpha,9abeta)-5,6-bis(Benzoyloxy)-5,5a,6,7,8,9-hexahydro-9-hydroxy-2,2,5a,9-tetramethyl-1-benzoxepin-9a(2H)-carboxylic acid

C29H32O8 (508.2097)

Mortonin D

(3alpha,4beta,6alpha,6abeta,7beta,10alpha,10aalpha)-10-Tetramethyl-6,7-bis(benzoyloxy)octahydro-10-hydroxy-3,4,6a 3H-3,10a-epoxy-1H-2-benzoxocin-1-one

C29H32O8 (508.2097)

(2R)-2-[(S)-3-hydroxy-3-methylglutaryloxy]putrescine dicinnamamide|pholiotic acid

C28H32N2O7 (508.2209)

cantleyanone C

C29H32O8 (508.2097)

Asp Phe Val Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-methylbutanamido]pentanedioic acid

C23H32N4O9 (508.2169)

Val Glu Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carboxybutanamido]-3-phenylpropanamido]butanedioic acid

C23H32N4O9 (508.2169)

Indacaterol Maleate

C28H32N2O7 (508.2209)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist Indacaterol maleate (QAB149) is an orally active ultra-long-acting β2 adrenergic receptor (ADRB2) agonist. Indacaterol maleate inhibits NF-κB activity in a β-arrestin2-dependent manner, preventing further lung damage and improving lung function in COPD (chronic obstructive pulmonary disorder). Indacaterol maleate can also be used in cardiovascular disease research[1][2].

Cys His His Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H32N8O5S (508.2216)

Cys His His Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H32N8O5S (508.2216)

Cys His Ile His

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

Cys His Leu His

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

Cys Ile His His

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

Cys Lys Met Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C19H36N6O6S2 (508.2138)

Cys Lys Gln Met

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C19H36N6O6S2 (508.2138)

Cys Leu His His

(2S)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

Cys Met Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]hexanamido]-4-carbamoylbutanoic acid

C19H36N6O6S2 (508.2138)

Cys Met Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]hexanoic acid

C19H36N6O6S2 (508.2138)

Cys Gln Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C19H36N6O6S2 (508.2138)

Cys Gln Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C19H36N6O6S2 (508.2138)

Asp Asp Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C23H32N4O9 (508.2169)

Asp Asp Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carboxypropanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C23H32N4O9 (508.2169)

Asp Asp Ile Phe

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S,2S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-methylbutyl]carbamoyl}propanoic acid

C23H32N4O9 (508.2169)

Asp Asp Leu Phe

(3S)-3-[(2S)-2-amino-3-carboxypropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}propanoic acid

C23H32N4O9 (508.2169)

Asp Glu Phe Val

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Asp Glu Val Phe

(4S)-4-[(2S)-2-amino-3-carboxypropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Asp Phe Asp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-carboxypropanamido]-3-methylpentanoic acid

C23H32N4O9 (508.2169)

Asp Phe Asp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-carboxypropanamido]-4-methylpentanoic acid

C23H32N4O9 (508.2169)

Asp Phe Glu Val

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Asp Phe Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-methylpentanamido]butanedioic acid

C23H32N4O9 (508.2169)

Asp Phe Leu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-4-methylpentanamido]butanedioic acid

C23H32N4O9 (508.2169)

Asp Ile Asp Phe

(3S)-3-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C23H32N4O9 (508.2169)

Asp Ile Phe Asp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanamido]-3-phenylpropanamido]butanedioic acid

C23H32N4O9 (508.2169)

Asp Leu Asp Phe

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C23H32N4O9 (508.2169)

Asp Leu Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanamido]-3-phenylpropanamido]butanedioic acid

C23H32N4O9 (508.2169)

Asp Val Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylbutanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Asp Val Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylbutanamido]-3-phenylpropanamido]pentanedioic acid

C23H32N4O9 (508.2169)

Glu Asp Phe Val

(4S)-4-amino-4-{[(1S)-2-carboxy-1-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-phenylethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Glu Asp Val Phe

(4S)-4-amino-4-{[(1S)-2-carboxy-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-methylpropyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Glu Phe Asp Val

(4S)-4-amino-4-{[(1S)-1-{[(1S)-2-carboxy-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}ethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Glu Phe Val Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-phenylpropanamido]-3-methylbutanamido]butanedioic acid

C23H32N4O9 (508.2169)

Glu Pro Thr Tyr

(4S)-4-amino-5-[(2S)-2-{[(1S,2R)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C23H32N4O9 (508.2169)

Glu Pro Tyr Thr

(4S)-4-amino-5-[(2S)-2-{[(1S)-1-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C23H32N4O9 (508.2169)

Glu Thr Pro Tyr

(4S)-4-amino-4-{[(2S,3R)-1-[(2S)-2-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Glu Thr Tyr Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C23H32N4O9 (508.2169)

Glu Val Asp Phe

(4S)-4-amino-4-{[(1S)-1-{[(1S)-2-carboxy-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}ethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Glu Val Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-methylbutanamido]-3-phenylpropanamido]butanedioic acid

C23H32N4O9 (508.2169)

Glu Tyr Pro Thr

(4S)-4-amino-4-{[(2S)-1-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Glu Tyr Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C23H32N4O9 (508.2169)

Phe Asp Asp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-carboxypropanamido]-3-methylpentanoic acid

C23H32N4O9 (508.2169)

Phe Asp Asp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-carboxypropanamido]-4-methylpentanoic acid

C23H32N4O9 (508.2169)

Phe Asp Glu Val

(4S)-4-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Phe Asp Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-methylpentanamido]butanedioic acid

C23H32N4O9 (508.2169)

Phe Asp Leu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-4-methylpentanamido]butanedioic acid

C23H32N4O9 (508.2169)

Phe Asp Val Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-methylbutanamido]pentanedioic acid

C23H32N4O9 (508.2169)

Phe Glu Asp Val

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1S)-2-carboxy-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Phe Glu Val Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-carboxybutanamido]-3-methylbutanamido]butanedioic acid

C23H32N4O9 (508.2169)

Phe Ile Asp Asp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-carboxypropanamido]butanedioic acid

C23H32N4O9 (508.2169)

Phe Leu Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-carboxypropanamido]butanedioic acid

C23H32N4O9 (508.2169)

Phe Val Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-carboxypropanamido]pentanedioic acid

C23H32N4O9 (508.2169)

Phe Val Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-4-carboxybutanamido]butanedioic acid

C23H32N4O9 (508.2169)

His Cys His Ile

(2S,3S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanoic acid

C21H32N8O5S (508.2216)

His Cys His Leu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanoic acid

C21H32N8O5S (508.2216)

His Cys Ile His

(2S)-2-[(2S,3S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

His Cys Leu His

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

His His Cys Ile

(2S,3S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-methylpentanoic acid

C21H32N8O5S (508.2216)

His His Cys Leu

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-methylpentanoic acid

C21H32N8O5S (508.2216)

His His Ile Cys

(2R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-sulfanylpropanoic acid

C21H32N8O5S (508.2216)

His His Leu Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-sulfanylpropanoic acid

C21H32N8O5S (508.2216)

His Ile Cys His

(2S)-2-[(2R)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

His Ile His Cys

(2R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C21H32N8O5S (508.2216)

His Leu Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

His Leu His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C21H32N8O5S (508.2216)

Ile Cys His His

(2S)-2-[(2S)-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

Ile Asp Asp Phe

(3S)-3-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C23H32N4O9 (508.2169)

Ile Asp Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanamido]-3-phenylpropanamido]butanedioic acid

C23H32N4O9 (508.2169)

Ile Phe Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-carboxypropanamido]butanedioic acid

C23H32N4O9 (508.2169)

Ile His Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

Ile His His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C21H32N8O5S (508.2216)

Lys Cys Met Gln

(2S)-4-carbamoyl-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]butanoic acid

C19H36N6O6S2 (508.2138)

Lys Cys Gln Met

(2S)-2-[(2S)-4-carbamoyl-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]butanamido]-4-(methylsulfanyl)butanoic acid

C19H36N6O6S2 (508.2138)

Lys Met Cys Gln

(2S)-4-carbamoyl-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]butanoic acid

C19H36N6O6S2 (508.2138)

Lys Met Gln Cys

(2R)-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]butanamido]-3-sulfanylpropanoic acid

C19H36N6O6S2 (508.2138)

Lys Gln Cys Met

(2S)-2-[(2R)-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C19H36N6O6S2 (508.2138)

Lys Gln Met Cys

(2R)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C19H36N6O6S2 (508.2138)

Leu Cys His His

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

Leu Asp Asp Phe

(3S)-3-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C23H32N4O9 (508.2169)

Leu Asp Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanamido]-3-phenylpropanamido]butanedioic acid

C23H32N4O9 (508.2169)

Leu Phe Asp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-carboxypropanamido]butanedioic acid

C23H32N4O9 (508.2169)

Leu His Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H32N8O5S (508.2216)

Leu His His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C21H32N8O5S (508.2216)

Met Cys Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]hexanamido]-4-carbamoylbutanoic acid

C19H36N6O6S2 (508.2138)

Met Cys Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]hexanoic acid

C19H36N6O6S2 (508.2138)

Met Lys Cys Gln

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C19H36N6O6S2 (508.2138)

Met Lys Gln Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C19H36N6O6S2 (508.2138)

Met Gln Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]hexanoic acid

C19H36N6O6S2 (508.2138)

Met Gln Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]hexanamido]-3-sulfanylpropanoic acid

C19H36N6O6S2 (508.2138)

Pro Glu Thr Tyr

(4S)-4-{[(1S,2R)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C23H32N4O9 (508.2169)

Pro Glu Tyr Thr

(4S)-4-{[(1S)-1-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}-2-(4-hydroxyphenyl)ethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C23H32N4O9 (508.2169)

Pro Thr Glu Tyr

(4S)-4-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-4-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanoic acid

C23H32N4O9 (508.2169)

Pro Thr Tyr Glu

(2S)-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-(4-hydroxyphenyl)propanamido]pentanedioic acid

C23H32N4O9 (508.2169)

Pro Tyr Glu Thr

(4S)-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}-4-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanoic acid

C23H32N4O9 (508.2169)

Pro Tyr Thr Glu

(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]pentanedioic acid

C23H32N4O9 (508.2169)

Gln Cys Lys Met

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C19H36N6O6S2 (508.2138)

Gln Cys Met Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C19H36N6O6S2 (508.2138)

Gln Lys Cys Met

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C19H36N6O6S2 (508.2138)

Gln Lys Met Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C19H36N6O6S2 (508.2138)

Gln Met Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]hexanoic acid

C19H36N6O6S2 (508.2138)

Gln Met Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]hexanamido]-3-sulfanylpropanoic acid

C19H36N6O6S2 (508.2138)

Thr Glu Pro Tyr

(4S)-4-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-[(2S)-2-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C23H32N4O9 (508.2169)

Thr Glu Tyr Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carboxybutanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C23H32N4O9 (508.2169)

Thr Pro Glu Tyr

(4S)-4-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Thr Pro Tyr Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanamido]pentanedioic acid

C23H32N4O9 (508.2169)

Thr Tyr Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C23H32N4O9 (508.2169)

Thr Tyr Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C23H32N4O9 (508.2169)

Val Asp Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carboxypropanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Val Asp Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carboxypropanamido]-3-phenylpropanamido]pentanedioic acid

C23H32N4O9 (508.2169)

Val Glu Asp Phe

(4S)-4-[(2S)-2-amino-3-methylbutanamido]-4-{[(1S)-2-carboxy-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Val Phe Asp Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-carboxypropanamido]pentanedioic acid

C23H32N4O9 (508.2169)

Val Phe Glu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-4-carboxybutanamido]butanedioic acid

C23H32N4O9 (508.2169)

Tyr Glu Pro Thr

(4S)-4-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-5-[(2S)-2-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C23H32N4O9 (508.2169)

Tyr Glu Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-carboxybutanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C23H32N4O9 (508.2169)

Tyr Pro Glu Thr

(4S)-4-{[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}butanoic acid

C23H32N4O9 (508.2169)

Tyr Pro Thr Glu

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]pentanedioic acid

C23H32N4O9 (508.2169)

Tyr Thr Glu Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C23H32N4O9 (508.2169)

Tyr Thr Pro Glu

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C23H32N4O9 (508.2169)

1,1,3,3,3,3-hexamethylindotricarbocyanine perchlorate

C29H33ClN2O4 (508.2129)

HL-Thr-OBzl * 0.5OxOH

C24H32N2O10 (508.2057)

VX-765

Belnacasan

C24H33ClN4O6 (508.2089)

C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C38461 - Caspase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

6-methylheptanoyloxy(7-methyloctanoyloxy)lead

C17H32O4Pb (508.2067)

L-Prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methylvalyl-N-(2-ethoxytetrahydro-5-oxo-3-furanyl)-

C24H33ClN4O6 (508.2089)

Indacaterol fumarate

C28H32N2O7 (508.2209)

2-[[6-(4-morpholinyl)-4-oxo-3-(2-phenylethyl)-2-quinazolinyl]thio]-N-(2-oxolanylmethyl)acetamide

C27H32N4O4S (508.2144)

N-[4-[[2-methoxy-5-[4-oxo-3-(pyridin-4-ylmethyl)-1,2-dihydroquinazolin-2-yl]phenyl]methoxy]phenyl]acetamide

C30H28N4O4 (508.211)

N-[5-(diethylsulfamoyl)-2-(4-morpholinyl)phenyl]-2,3-dihydro-1H-cyclopenta[b]quinoline-9-carboxamide

C27H32N4O4S (508.2144)

N-[(1S,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C28H32N2O7 (508.2209)

N-[(1R,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C28H32N2O7 (508.2209)

N-[(1R,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C28H32N2O7 (508.2209)

N-[(1S,3S,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C28H32N2O7 (508.2209)

N-[(1R,3S,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C28H32N2O7 (508.2209)

N-[(1S,3R,4aS,9aR)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C28H32N2O7 (508.2209)

N-[(1S,3R,4aR,9aS)-3-[2-(cyclohexylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide

C28H32N2O7 (508.2209)

N-[4-[[2-(diethylamino)ethylamino]-oxomethyl]phenyl]-3-[(4-methylphenyl)sulfamoyl]benzamide

C27H32N4O4S (508.2144)

6-O-Oleuropeoylsucrose

C22H36O13 (508.2156)

ST 26:5;O5;S

C26H36O8S (508.2131)

BI-1622

C26H24N10O2 (508.2084)

BI-1622 is an orally active, potent and highly selective HER2 (ERBB2) inhibitor, with an IC50 of 7 nM. BI-1622 shows greater than 25-fold selectivity over EGFR. BI-1622 shows high antitumor efficacy in vivo in xenograft mouse tumor models with engineered H2170 and PC9 cells and had a favorable agent metabolism and pharmacokinetics profile[1].

(9r)-3,4,5,19-tetramethoxy-9,10-dimethyl-8-phenoxy-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2(7),3,5,13,18-hexaen-9-ol

C29H32O8 (508.2097)

5-(benzoyloxy)-2-hydroxy-2,6,9,10-tetramethyl-12-oxo-11,13-dioxatricyclo[8.2.1.0¹,⁶]tridecan-7-yl benzoate

C29H32O8 (508.2097)

5,6-bis(benzoyloxy)-9-hydroxy-2,2,5a,9-tetramethyl-5,6,7,8-tetrahydro-1-benzoxepine-9a-carboxylic acid

C29H32O8 (508.2097)

[(1s)-2-{2-[(1s,2s,3s,7as)-1,7-dihydroxy-3,7a-dimethyl-5-[(3-methylbut-2-enoyl)imino]-2,3-dihydro-1h-pyrrolizin-2-ylsulfinyl]-3h-imidazol-4-yl}-1-carboxyethyl]trimethylazanium

[C23H34N5O6S]+ (508.223)

methyl 4-hydroxy-3-[(2r,3r)-6-hydroxy-2-(2-hydroxypropan-2-yl)-4-methoxy-7-(3-phenylpropanoyl)-2,3,6,7-tetrahydro-1-benzofuran-3-yl]benzoate

C29H32O8 (508.2097)

n-[(2s,3r,4r,6r)-16-hydroxy-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-4-yl]-n-methylacetamide

n-[(2s,3r,4r,6r)-16-hydroxy-3-methoxy-2-methyl-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1²,⁶.0⁷,²⁸.0⁸,¹³.0¹⁵,¹⁹.0²⁰,²⁷.0²¹,²⁶]nonacosa-8(13),9,11,14(28),15(19),16,20(27),21(26),22,24-decaen-4-yl]-n-methylacetamide

C30H28N4O4 (508.211)

11-hydroxy-7-(2-hydroxypropan-2-yl)-16-methoxy-20,20-dimethyl-18-(3-methylbut-2-en-1-yl)-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4,6,9,11,14-pentaene-13,17-dione

C29H32O8 (508.2097)

methyl 4-hydroxy-3-[6-hydroxy-2-(2-hydroxypropan-2-yl)-4-methoxy-7-(3-phenylpropanoyl)-2,3,6,7-tetrahydro-1-benzofuran-3-yl]benzoate

C29H32O8 (508.2097)

(5r,5as,6s,9s,9ar)-5,6-bis(benzoyloxy)-9-hydroxy-2,2,5a,9-tetramethyl-5,6,7,8-tetrahydro-1-benzoxepine-9a-carboxylic acid

C29H32O8 (508.2097)

(5s,5as,6s,9s,9as)-5,6-bis(benzoyloxy)-9-hydroxy-2,2,5a,9-tetramethyl-5,6,7,8-tetrahydro-1-benzoxepine-9a-carboxylic acid

C29H32O8 (508.2097)

5-({1,4-bis[(1-hydroxy-3-phenylprop-2-en-1-ylidene)amino]butan-2-yl}oxy)-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H32N2O7 (508.2209)

(9s,10s,11s)-3,4,5,19-tetramethoxy-9,10-dimethyl-11-phenoxy-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2(7),3,5,13,18-hexaen-10-ol

C29H32O8 (508.2097)

(8r,9s,10s)-5,14-dihydroxy-3,4,15,16-tetramethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(16),2(7),3,5,12,14-hexaen-8-yl benzoate

C29H32O8 (508.2097)

(8s,9r,10s)-3,4,5,19-tetramethoxy-9,10-dimethyl-8-phenoxy-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2(7),3,5,13,18-hexaen-9-ol

C29H32O8 (508.2097)

(4r)-4-{4,7-dimethoxy-9h-pyrido[3,4-b]indol-1-yl}-7,10-dimethoxy-1h,2h,3h,4h-indolo[2,3-a]quinolizine

C30H28N4O4 (508.211)

(4s)-4-{4,7-dimethoxy-9h-pyrido[3,4-b]indol-1-yl}-7,10-dimethoxy-1h,2h,3h,4h-indolo[2,3-a]quinolizine

C30H28N4O4 (508.211)

(3s)-5-{[(2r)-1,4-bis({[(2e)-1-hydroxy-3-phenylprop-2-en-1-ylidene]amino})butan-2-yl]oxy}-3-hydroxy-3-methyl-5-oxopentanoic acid

C28H32N2O7 (508.2209)

(2e,4e,6e)-n-[(3s,4r)-3,4-dihydroxy-3-[(1e,3e,5e)-6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl]-6-oxocyclohex-1-en-1-yl]-8-methylnona-2,4,6-trienimidic acid

C28H32N2O7 (508.2209)

n-(3,4-dihydroxy-3-{6-[(2-hydroxy-5-oxocyclopent-1-en-1-yl)-c-hydroxycarbonimidoyl]hexa-1,3,5-trien-1-yl}-6-oxocyclohex-1-en-1-yl)-8-methylnona-2,4,6-trienimidic acid

C28H32N2O7 (508.2209)

(1r,2r,16s,18s)-11-hydroxy-7-(2-hydroxypropan-2-yl)-16-methoxy-20,20-dimethyl-18-(3-methylbut-2-en-1-yl)-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4,6,9,11,14-pentaene-13,17-dione

(1r,2r,16s,18s)-11-hydroxy-7-(2-hydroxypropan-2-yl)-16-methoxy-20,20-dimethyl-18-(3-methylbut-2-en-1-yl)-3,8,19-trioxahexacyclo[14.4.1.0²,¹⁴.0²,¹⁸.0⁴,¹².0⁵,⁹]henicosa-4,6,9,11,14-pentaene-13,17-dione

C29H32O8 (508.2097)

4-{4,7-dimethoxy-9h-pyrido[3,4-b]indol-1-yl}-7,10-dimethoxy-1h,2h,3h,4h-indolo[2,3-a]quinolizine

C30H28N4O4 (508.211)

5,14-dihydroxy-3,4,15,16-tetramethoxy-9,10-dimethyltricyclo[10.4.0.0²,⁷]hexadeca-1(16),2(7),3,5,12,14-hexaen-8-yl benzoate

C29H32O8 (508.2097)